7 minute read

Guest editorial

Next Article
Safe medication

Safe medication

Provincial and federal governments must both take immediate action on medicare crisis

By Colleen M. Flood

Across Canada, people are going without the health care they need. Emergency rooms waits are counted in days not hours. Far too many Canadians, even those with critical illnesses, have no primary care provider or the wait for an appointment is too long and so they must turn to walk-in clinics or wait in crowded emergency rooms.

Hospital staff and their families are falling sick from COVID-19 and unable to work or, burnt-out, retire early or change jobs. This is unsurprising, after nearly three years of battling wave after wave of COVID-19, and with the coming winter months threatening a further surge.

Provincial governments, instead of responding to the problem with the urgency required, have launched a media campaign for more federal funding. The federal government has been content to sit on its hands, avoiding responsibility for health care, spinning the same old yarn that responsibility rests with the provinces. Medical associations stick to the refrain of needing more investments largely in support of the status quo and/or calling for reforms that will have little or no immediate impact for patients.

It is a dangerous time for public medicare and for Canadians. Pro-privatization doctors and associated businesses are pushing hard to take advantage of Canadians’ fears and frustration that their loved ones will suffer with unmet health needs.

But the promises of reduced wait times through privatization ring false for most Canadians.

The pandemic has seriously impacted the supply of nurses and doctors. If the rich or well insured can pay more for care, then the current access problems will worsen for all those who have no choice but to rely on public medicare.

Privatization would also mean Canadians in remote and rural areas would face even greater hurdles to access care as physicians migrate to metropolitan areas to provide more lucrative services to urban dwellers. Higher prices paid to doctors and nurses in the private tier would also increase the prices that would have to be paid by public medicare to keep them in the system.

If privatization is a snake-oil solution, what is to be done? We need to apply pressure to both levels of government to attend to this crisis now.

Provinces need to take bold steps, including: • Alleviate the administrative burden and cost of business on doctors by setting up publicly run clinics staffed by family practice teams paid on a salary basis. • Immediate increase in nurses’ pay and higher fee per patient for those family doctors who add high-need patients to their rosters. • Permit additional billing for virtual care for primary care teams willing to enrol more patients and to enable both family doctors and specialists to provide additional services to patients in remote and rural areas. • Establish urgent care centres to divert more non-critical patients from the emergency department. Continued on page 6

UPCOMING DEADLINES

JANUARY 2023 ISSUE

EDITORIAL: December 6 ADVERTISING: Display – Dec. 14 | Material – Dec. 16 Monthly Focus: Professional Development/Continuing Medical Education (CME)/Human Resources: Continuing Medical Education (CME) for healthcare professionals. The use of simulation in training. Human resource programs implemented to manage stress in the workplace and attract and retain healthcare staff. Health and safety issues for healthcare professionals. Quality work environment initiatives and outcomes. + PROFESSIONAL DEVELOPMENT SUPPLEMENT

FEBRUARY 2023 ISSUE

EDITORIAL: January 12 ADVERTISING: Display – Jan. 20 | Material – Jan. 24 Monthly Focus: Gerontology/Alternate Level of Care/Rehab/ Wound Care/Procurement: Geriatric medicine, aging-related health issues and senior friendly strategies. Best practices in care transitions that improve patient flow through the continuum of care. Rehabilitation techniques for a variety of injuries and diseases. Innovation in the treatment and prevention of wounds. + WOUND CARE SUPPLEMENT

610 Applewood Crescent, Suite 401 Vaughan Ontario L4K 0E3 TEL. 905.532.2600|FAX 1.888.546.6189 www.hospitalnews.com

Editor Kristie Jones

editor@hospitalnews.com Advertising Representatives Denise Hodgson

denise@hospitalnews.com Publisher Stefan Dreesen

stefan@hospitalnews.com Accounting Inquiries accountingteam@mediaclassified.ca

Circulation Inquiries info@hospitalnews.com

Director of Print Media Lauren Reid-Sachs

Senior Graphic Designer Johannah Lorenzo

ADVISORY BOARD

Barb Mildon,

RN, PHD, CHE VP Professional Practice & Research & CNE, Ontario Shores Centre for Mental Health Sciences Helen Reilly,

Publicist Health-Care Communications Jane Adams,

President Brainstorm Communications & Creations Bobbi Greenberg,

Health care communications Sarah Quadri Magnotta,

Health care communications Dr. Cory Ross,

B.A., MS.C., DC, CSM (OXON), MBA, CHE Vice President, Academic George Brown College, Toronto, ON

ASSOCIATE PARTNERS:

Hospital News is published for hospital health-care professionals, patients, visitors and students. It is available free of charge from distribution racks in hospitals in Ontario. Bulk subscriptions are available for hospitals outside Ontario. The statements, opinions and viewpoints made or expressed by the writers do not necessarily represent the opinions and views of Hospital News, or the publishers. Hospital News and Members of the Advisory Board assume no responsibility or liability for claims, statements, opinions or views, written or reported by its contributing writers, including product or service information that is advertised. Changes of address, notices, subscriptions orders and undeliverable address notifications. Subscription rate in Canada for single copies is $29.40 per year. Send enquiries to: subscriptions@ hospitalnews.com Canadian Publications mail sales product agreement number 42578518.

NEWS World’s largest autism whole genome sequencing study reveals 134 autism-linked genes

Researchers from The Hospital for Sick Children (SickKids) have uncovered new genes and genetic changes associated with autism spectrum disorder (ASD) in the largest autism whole genome sequencing analysis to date, providing better understanding into the ‘genomic architecture’ that underlies this disorder.

The study, published today in Cell, used whole genome sequencing (WGS) to examine the entire genomes of over 7,000 individuals with autism as well as an additional 13,000 siblings and family members. The team found 134 genes linked with ASD and discovered a range of genetic changes, most notably gene copy number variations (CNVs), likely to be associated with autism, including ASD-associated rare variants in about 14 per cent of participants with autism.

The majority of data was drawn from the Autism Speaks MSSNG database, the world’s largest autism whole genome dataset, which provides autism researchers with free, open access to thousands of sequenced genomes.

“By sequencing the entire genome of all participants, and with deep involvement from the participating families in MSSNG on forming our research priorities, we maximize the potential for discovery and allow analysis that encompasses all types of variants, from the smallest DNA changes to those that affect entire chromosomes,” says Dr. Stephen Scherer, Senior Scientist, Genetics & Genome Biology and Chief of Research at SickKids, and Director of the McLaughlin Centre at the University of Toronto.

Dr. Brett Trost, lead author of the paper and a Research Associate in the Genetics & Genome Biology program at SickKids, notes the use of WGS allowed researchers to uncover variant types that would not have otherwise been detectable. These variant types include complex rearrangements of DNA, as well as tandem repeat expansions, a finding supported by recent SickKids research on the link between autism and DNA segments that are repeated many times. The role of the maternally inherited mitochondrial DNA was also examined in the study and found to account for two per cent of autism.

The paper also points to important nuances in autism genetics in families with only one individual with autism compared with families that have multiple individuals with autism, known as multiplex families. Surprising to the team was that the “polygenic score” – an estimation of the likelihood of an individual having autism, calculated by aggregating the effects of thousands of common variants throughout the genome – was not higher among multiplex families.

“This suggests that autism in multiplex families may be more likely to be linked to rare, highly impactful variants inherited from a parent. Because both the genetics and clinical traits associated with autism are so complex and varied, large data sets like the ones we used are critical to providing researchers with a clearer understanding of the genetic architecture of autism,” says Trost.

The research team says the study data can help expand inquiries into the range of variants that might be linked to ASD, as well as efforts to better understand contributors to the 85 per cent of autistic individuals for which the genetic cause remains unresolved. In a linked study of 325 families with ASD from Newfoundland published this same month in Nature Communications, Dr. Scherer’s team found that combinations of spontaneous, rare-inherited, and polygenic genetic factors coming together in the same individual can potentially lead to different sub-types of autism.

Dr. Suzanne Lewis, a geneticist and investigator at the BC Children’s Hospital Research Institute who diagnosed many of the families enrolled in the study said, “Collectively, these latest findings represent a massive step forward in better understanding the complex genetic and biological circuitry linked with ASD. This rich data set also offers an opportunity to dive deeper into examining other factors that may determine an individual’s chance of developing this complex condition to help individualize future treatment approaches.”

Funding for this study was provided by the University of Toronto McLaughlin Centre, Genome Canada/ Ontario Genomics, Genome BC, Government of Ontario, Canadian Institutes of Health Research, Canada Foundation for Innovation, Autism Speaks, Autism Speaks Canada, Brain Child, Kids Brain Health Network, Qatar National Research Fund, Ontario Brain Institute, SFARI and SickKids Foundation. ■ H

This article is from: